Product Description
Irinotecan HCL Trihydrate is an injectable solution primarily used in the treatment of colorectal and other cancers. It is recommended for cancer patients undergoing chemotherapy, with a typical dosage of 125 mg/m administered intravenously as prescribed by the oncologist. This chemotherapeutic agent is administered under the supervision of a qualified healthcare professional, often in combination with other medications. Suitable for adults, each box contains 1 vial of Irinotecan HCL Trihydrate, with varying quantities of 40mg/2mL or 100mg/5mL per vial. The synthetic origin of this medicine ensures consistent quality, and it should be stored at 2C to 8C, protected from light and avoiding freezing.
FAQs of Irinotecan HCL tRIHYDRATE:
Q: What is the recommended dosage of Irinotecan HCL Trihydrate?
A: The recommended dosage is typically 125 mg/m administered intravenously as prescribed by the oncologist.
Q: How should Irinotecan HCL Trihydrate be stored?
A: It should be stored at 2C to 8C, protected from light and avoiding freezing.
Q: What is the primary function of Irinotecan HCL Trihydrate?
A: It is primarily used in the treatment of colorectal and other cancers.
Q: Who is Irinotecan HCL Trihydrate suitable for?
A: It is suitable for adults undergoing chemotherapy for cancer treatment.
Q: What is the packaging quantity of Irinotecan HCL Trihydrate?
A: Each box contains 1 vial of varying quantities of 40mg/2mL or 100mg/5mL per vial.